CD4-VioGreen (Clone REA623) - REA623 recognizes the human CD4 antigen, a 55 kDa - Miltenyi Biotec B.V. & Co. KG

Duns Number:342920388

Device Description: REA623 recognizes the human CD4 antigen, a 55 kDa single-pass type I membrane protein, als REA623 recognizes the human CD4 antigen, a 55 kDa single-pass type I membrane protein, also known as T4/Leu-3. CD4 is highly expressed on T helper cells and at a lower level on monocytes and dendritic cells. It is involved in the recognition of MHC class ll/peptide complexes by the TCR heterodimers and is the receptor for the human immunodeficiency virus (HIV). Additional information: Clone REA623 displays negligible binding to Fc receptors.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

CD4-VioGreen (Clone REA623)

Version/Model Number

170-081-084

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

MVU

Product Code Name

Reagents, Specific, Analyte

Device Record Status

Public Device Record Key

989e7272-f91b-44a6-95b0-05d009bddc8e

Public Version Date

April 05, 2021

Public Version Number

1

DI Record Publish Date

March 26, 2021

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"MILTENYI BIOTEC B.V. & CO. KG" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 88